Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-β1b-treated multiple sclerosis patients

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 174-177

  Ferrarini, A M ^a   Sivieri, S ^a   Buttarello, M ^a   Facchinetti, A ^a   Perini, P ^a   Gallo, P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CD25; CD4; HLA DR; Interferon beta 1b; Lymphocyte subsets; Multiple sclerosis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; HLA DR ANTIGEN; INTERFERON BETA SERINE; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; LYMPHOCYTE SUBPOPULATION; MULTIPLE SCLEROSIS; T LYMPHOCYTE;

EID: 0031690639     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245898678909286     Document Type: Article

References (19)

1. The IFNB Multiple Sclerosis Study Group. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655 - 661.
2. Paty DW, Li DKB, the UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. (1993) Interferon beta 1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 662 - 667.
3. de Maeyer E, de Maeyer-Guignard J. (1991) Interferons. In: Thomson A (ed.). The cytokine handbook, Academic Press Ltd: New York, pp. 215 - 239.
4. Larocca AP, Borden EC, Colby CB. (1992) Human Interferon Beta. In: Aggarwal BB, Gutterman JU (eds). Human cytokines. Handbook for basic and clinical research, Blackwell Scientific Publication: London, pp. 17 - 29.
5. Wienstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. (1995) The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 37: 7 - 15.
6. Jacobs L. Johnson KP. (1994) A brief history of the use of interferons as treatment of multiple sclerosis. Arch Neurol 51: 1245 - 1252.
7. Nohoronha A, Toscas A, Jensen MA. (1993) Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J Neuroimmunol 46: 145 - 154.
8. Rudick RA et al. (1993) In vitro and in vivo inhibition of mitogen-driven T cell activation by recombinant interferon beta. Neurology 43: 2080 - 2087.
9. Brod SA et al. (1996) Interferon-β1b treatment decreases tumor necrosis factor alpha and increases interleukin-6 production in multiple sclerosis. Neurology 46: 1633 - 1638.
10. Ling PD, Warren MK, Vogel SN. (1985) Antagonistic effect of interferon beta on the interferon gamma induced expression of la antigen in murine macrophages. J Immunol 135: 1857 - 1863.
11. Inaba K et al. (1986) Contrasting effects of alpha/beta-and gamma-interferons on expression of macrophage la antigens. J Exp Med 163: 1030 - 1035.
12. Rudick RA et al. (1993) In vitro and in vivo inhibition of nitrogen-driven T-cell activation by recombinant interferon beta. Neurology 43: 2080 - 2087.
13. Leppert D et al. (1996) Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 40: 846 - 852.
14. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis : guidelines for research protocols. Ann Neurol 13: 227 - 231.
15. Kurzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444 - 1452.
16. Larocca AP et al. (1989) Evaluation of neutralizing antibodies in patients treated with recombinant interferon-βser. J Interferon Res 9 (Suppl 1): S51 - S60.
17. Dayal AS, Jensen MA, Lledo A, Arnason BGW. (1995) Interferon gamma-secreting cells in multiple sclerosis patients treated with interferon beta-lb. Neurology 45: 2173 - 2177.
18. Pette M et al. (1997) Interferon-β interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes. Neurology 49: 385 - 392.
19. Pachner AR. (1997) Anticytokine antibodies in beta interferon-treated MS patients and the need for testing: plight of the practicing neurologist. Neurology 49: 647 - 650.